Last reviewed · How we verify
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
The goal of this post-market clinical follow up Study is to demonstrate the efficacy, safety, acceptability, and quality of life implications of Essilor® Stellest® spectacle lenses in slowing myopia progression in European children and adolescents. Participants will receive Essilor® Stellest® at inclusion visit and will be asked for a full time wear (\>12 hours daily) for 24 months. The primary endpoints are the change in axial length and cycloplegic autorefraction from baseline to 24 months compared to expected change based on axial length and refraction centile positions at baseline.
Details
| Lead sponsor | Essilor International |
|---|---|
| Phase | NA |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 150 |
| Start date | Fri Mar 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Apr 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Myopia
Interventions
- Essilor® Stellest® spectacle lenses
Countries
France, Ireland, Netherlands